| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/15/2000 | US6025142 Hydrophobic u-PAR binding site |
| 02/15/2000 | US6024960 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |
| 02/15/2000 | US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
| 02/15/2000 | US6024956 Interleukins and antiinflammatrory agents |
| 02/15/2000 | US6024940 Antiinflammatory agents for mammals |
| 02/15/2000 | CA2197739C 1,4-dihydropyridine compounds |
| 02/15/2000 | CA2152792C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 02/10/2000 | WO2000006769A2 Human ccr-2 gene polymorphisms |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006698A1 98 human secreted proteins |
| 02/10/2000 | WO2000006604A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006588A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 02/10/2000 | WO2000006580A1 Pyridobenzothiazine derivatives and process for producing the same |
| 02/10/2000 | WO2000006578A1 Pyridobenzoxazine derivatives and process for producing the same |
| 02/10/2000 | WO2000006572A1 Bensoquinolizine derivatives and process for producing the same |
| 02/10/2000 | WO2000006571A1 Pyrroloquinoline derivatives and process for producing the same |
| 02/10/2000 | WO2000006569A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 02/10/2000 | WO2000006568A1 Substituted pyrazole derivatives |
| 02/10/2000 | WO2000006567A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine |
| 02/10/2000 | WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity |
| 02/10/2000 | WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | WO2000006545A1 High affinity ligands for nociceptin receptor orl-1 |
| 02/10/2000 | WO2000006544A1 Cyclic amine derivatives and process for the preparation thereof |
| 02/10/2000 | WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 02/10/2000 | WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006190A1 THYMOSIN β4 PROMOTES WOUND REPAIR |
| 02/10/2000 | WO2000006187A2 Modulation of apoptosis |
| 02/10/2000 | WO2000006169A1 Integrin receptor antagonists |
| 02/10/2000 | WO2000006153A1 Propenamides as ccr5 modulators |
| 02/10/2000 | WO2000006146A1 Substituted anilide compounds and methods |
| 02/10/2000 | WO2000006137A2 Glucocorticoid-selective anti-inflammatory agents |
| 02/10/2000 | WO2000006125A1 Fast dissolving ibuprofen containing compositions having analgesic activity |
| 02/10/2000 | WO2000006085A2 Compounds and methods |
| 02/10/2000 | WO2000000510A8 Growth factor modulators |
| 02/10/2000 | WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2 |
| 02/10/2000 | WO1999060024A9 Methods for amyloid removal using anti-amyloid antibodies |
| 02/10/2000 | WO1999058139A3 Methods for detecting and inhibiting angiogenesis |
| 02/10/2000 | WO1999045910A3 Methods and compositions for treating and preventing mucositis |
| 02/10/2000 | WO1999045126A3 Enhanced prodrug activation |
| 02/10/2000 | DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use |
| 02/10/2000 | CA2339301A1 Hdpbo81 nucleic acids and polypeptides |
| 02/10/2000 | CA2339096A1 Modulation of apoptosis |
| 02/10/2000 | CA2339071A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 02/10/2000 | CA2338928A1 Thymosin .beta.4 promotes wound repair |
| 02/10/2000 | CA2338804A1 Propenamides as ccr5 modulators |
| 02/10/2000 | CA2338764A1 Substituted anilide compounds and methods |
| 02/10/2000 | CA2338697A1 Compounds and methods |
| 02/10/2000 | CA2338275A1 Integrin receptor antagonists |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | CA2333854A1 Stereoisomers of cpg oligonucleotides and related methods |
| 02/09/2000 | EP0978561A1 Antisense oligonucleotides for the inhibition of VEGF expression |
| 02/09/2000 | EP0978287A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT |
| 02/09/2000 | EP0978277A1 Antirheumatic agents |
| 02/09/2000 | EP0977859A1 The neurotrophic factor nnt-1 |
| 02/09/2000 | EP0977852A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/09/2000 | EP0977850A1 Edg-1-like receptor |
| 02/09/2000 | EP0977758A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 02/09/2000 | EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 02/09/2000 | EP0977748A1 Substituted benzopyran derivatives for the treatment of inflammation |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977743A1 Protease inhibitors |
| 02/09/2000 | EP0977741A1 Substituted phenyl derivatives, their preparation and use |
| 02/09/2000 | EP0977735A1 Vitronectin receptor antagonists |
| 02/09/2000 | EP0977733A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 02/09/2000 | EP0977586A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 02/09/2000 | EP0977581A1 Histone containing composition to treat rheumatoid arthritis |
| 02/09/2000 | EP0977565A1 Pharmaceutical composition |
| 02/09/2000 | EP0977562A1 Methods and compositions for delivery of taxanes |
| 02/09/2000 | EP0977560A1 IBUPROFEN THIOESTERS AS INHIBITORS OF Nf-kappaB-DEPENDENT PAIN AND INFLAMMATION MEDIATOR FORMATION |
| 02/09/2000 | EP0822934B1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/09/2000 | CN1244128A Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 02/09/2000 | CN1244121A Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 02/09/2000 | CN1243827A Preparation of heterocyclic amide derivative with specific physical status |
| 02/09/2000 | CN1243745A Chinese patent medicine for treating headache |
| 02/09/2000 | CN1243741A Analgesic for treating rheumatic and rheumtoid diseases |
| 02/09/2000 | CN1243737A Medicinal capsule for treating stomach-ache |
| 02/09/2000 | CN1243717A Medicine for curing common cold and cough and its preparing process |
| 02/09/2000 | CN1243703A Snake wine |
| 02/08/2000 | US6022984 Efficient synthesis of furan sulfonamide compounds useful in the synthesis of new IL-1 inhibitors |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022971 Azetidines |
| 02/08/2000 | US6022969 Symmetrical bis(aminoalkyl), bis(amidinoalkyl) and bis(guanidinoalkyl) cycloalkanes |
| 02/08/2000 | US6022900 Preventing and ameliorating cachexia; treating whole body nitrogen loss associated with catabolic illness by inhibiting synthesis of urea from plasma arginine |
| 02/08/2000 | US6022898 Metalloproteinase inhibitors |
| 02/08/2000 | US6022895 Substituted amino compounds and their use as substances having an analgesic effect |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022875 Use of substituted 2,4-imidazolidinedione compounds as analgesics |
| 02/08/2000 | US6022873 Metalloproteinase inhibitors |
| 02/08/2000 | US6022546 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 02/08/2000 | CA2150016C Pyrrolopyrimidines as crf antagonists |
| 02/08/2000 | CA2014467C 3-substituted-2-oxindole derivatives |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005375A1 Gbs toxin receptor |